DENVER, May 14, 2019 (GLOBE NEWSWIRE) -- Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have partnered with Cambrian Alliance (CA), one of the largest buying groups for independent pharmacies in the United Kingdom. The partnership allows CA members to access Elixinol brand products, an exclusive launch offer package, point of sale material and staff training.
“We are delighted to work in partnership with Elixinol, providing our members with access to a new range of products,” said Nathan Wiltshire, CEO of Cambrian Alliance. “Our active goal is to help our members grow their businesses and increase their profits, and this new partnership strengthens our commitment to ensuring this ambition.”
Elixinol is in the process of developing an interactive training platform for CA members in support of the partnership. This platform will help members explain the various benefits of Elixinol products to their customers and maximize CBD revenue opportunities. The deal will be offered across Cambrian’s 1,200 member stores, with each store independently deciding on offer integration.
“As one of the most trusted industry leaders, Elixinol is delighted to work with Cambrian Alliance as the organization and its membership share our core values and commitment to excellence,” said Ali Atcha, Sales & Marketing Director at Elixinol Europe. “We will be offering unrivaled retail support to member pharmacies looking to grow their business with our high quality, trusted CBD products.”
Gravells Pharmacy, a Cambrian Alliance member store in South Wales, is already experiencing the benefits of retailing Elixinol CBD products. James Thorne from Gravells commented, “I’ve tried around ten different CBD brands with my customers and nothing I’ve found in the marketplace can touch Elixinol for quality and effectiveness. Our sales are growing fast.”
About Elixinol:
Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD. Elixinol’s parent company EXL (elixinolglobal.com) is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX: ELLXF). More information available at Elixinol.com.
About Cambrian Alliance:
The Cambrian Alliance Group is one of the UK’s largest pharmacy buying groups with over 1,200 members, working with leading suppliers including AAH and Alliance Healthcare. It was launched in 2000 by six community pharmacists who continue to direct the company. With core values of integrity, honesty, personalization and transparency, the organization boasts 10 regional Business Managers covering the whole of the UK to advise and support its members, as well as a dedicated PMR-based price comparison, stock ordering tool e-CASS is used by over 600 pharmacies.
Media Contact:
Blythe Tokar
MULTIPLY
202-292-4573
multiply@elixinol.com
Chris Husong
Elixinol
+1 844-804-3504 ext 420
chris@elixinol.com